Neuberger Comments on Prospects for Marijuana Breathalyzer Test
23 October 2019
Business Insurance
Of Counsel Mark Neuberger was quoted in a Business Insurance article, “Marijuana drug test in works; could be relief for employers,” about the development of a new type of drug test for marijuana use that is set to hit the market next year.
Neuberger, co-chair of Foley’s Cannabis Industry Team, suggested that employers conduct field sobriety tests on employees suspected of marijuana impairment instead of just sending them out for drug testing. “There’s scientific evidence behind that” and it’s legally acceptable, he said. “You don’t need to be a law enforcement person to get training. If you suspect an employee in the workplace is impaired…put them through the test and make a reasonable determination.”
Neuberger, co-chair of Foley’s Cannabis Industry Team, suggested that employers conduct field sobriety tests on employees suspected of marijuana impairment instead of just sending them out for drug testing. “There’s scientific evidence behind that” and it’s legally acceptable, he said. “You don’t need to be a law enforcement person to get training. If you suspect an employee in the workplace is impaired…put them through the test and make a reasonable determination.”
People
Related News
14 February 2025
In the News
Brian Wheeler Joins Podcast to Discuss Legal Journey
Foley & Lardner LLP partner Brian Wheeler joined the Hsu Untied podcast to discuss his legal career.
14 February 2025
In the News
Pavan Agarwal Featured in Leadership Q&A – 'Reflecting our firm’s core values drives me to do my best'
Foley & Lardner LLP partner Pavan Agarwal is featured by Law.com for his career journey, legal practice, and leadership in the article, “How I Made Practice Group Chair: ‘Keep Listening and Keep Learning,’ Says Pavan Agarwal of Foley & Lardner.”
14 February 2025
In the News
Judith Waltz on Trump Administration Deregulation Order, Impact on CMS
Foley & Lardner LLP partner Judith Waltz commented on the Trump administration's executive order requiring federal agencies cut ten regulations for each newly created one in the Modern Healthcare article, "CMS may evade Trump's sweeping deregulation order."